Technical Analysis for NVCR - NovoCure Limited

Grade Last Price % Change Price Change
F 13.82 -1.14% -0.16
NVCR closed down 1.14 percent on Monday, March 18, 2024, on approximately normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish -1.14%
New Downtrend Bearish -1.14%
Lower Bollinger Band Walk Weakness -1.14%

   Recent Intraday Alerts

Alert Time
Up 2% about 17 hours ago
60 Minute Opening Range Breakout about 19 hours ago
Up 1% about 19 hours ago
Rose Above Lower Bollinger Band about 20 hours ago
Fell Below Previous Day's Low about 20 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

NovoCure Limited develops and commercializes treatment for solid tumor cancers therapy called the tumor treating fields (TTFields). The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer. NovoCure Limited also conducts clinical trials for the use of TTFields in brain metastases, advanced non-small cell lung cancer, pancreatic cancer, ovarian cancer, and mesothelioma. The company markets its products in the United States, as well as in European Union member states, Switzerland, and Japan. NovoCure Limited was founded in 2000 and is based in Saint Helier, Channel Islands.
Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine Cancer Clinical Medicine Oncology Tumor Non Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer Small Cell Lung Cancer Blastoma Glioblastoma Brain Tumor Solid Tumor Cancers Aging Associated Diseases Helio Metastases Brain Cancer Mesothelioma

Is NVCR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 83.6
52 Week Low 10.87
Average Volume 1,195,766
200-Day Moving Average 22.35
50-Day Moving Average 14.90
20-Day Moving Average 15.62
10-Day Moving Average 15.53
Average True Range 0.91
RSI (14) 38.65
ADX 29.4
+DI 22.72
-DI 23.92
Chandelier Exit (Long, 3 ATRs) 15.32
Chandelier Exit (Short, 3 ATRs) 16.53
Upper Bollinger Bands 17.39
Lower Bollinger Band 13.85
Percent B (%b) -0.01
BandWidth 22.64
MACD Line -0.13
MACD Signal Line 0.21
MACD Histogram -0.3378
Fundamentals Value
Market Cap 1.48 Billion
Num Shares 107 Million
EPS -1.86
Price-to-Earnings (P/E) Ratio -7.43
Price-to-Sales 3.35
Price-to-Book 4.16
PEG Ratio -0.47
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.58
Resistance 3 (R3) 14.66 14.49 14.45
Resistance 2 (R2) 14.49 14.29 14.45 14.41
Resistance 1 (R1) 14.15 14.17 14.07 14.07 14.37
Pivot Point 13.98 13.98 13.94 13.94 13.98
Support 1 (S1) 13.65 13.79 13.56 13.57 13.27
Support 2 (S2) 13.48 13.67 13.44 13.23
Support 3 (S3) 13.14 13.48 13.19
Support 4 (S4) 13.06